Skip to main content

Palestinians receive first batch of vaccines through COVAX

More than 60,000 doses of the AstraZeneca and Pfizer/BioNTech vaccines arrived in Ramallah on Wednesday.

A worker unloads a refrigerated truck carrying the first delivery of coronavirus vaccine via the United Nations Covax programme supporting poorer areas, to be kept at Palestinian Authority's storage facility in the West Bank city of Nablus, on March 17, 2021. - The Palestinian Authority said that vaccination would begin at the end of this week, primarily for those aged over 75, cancer patients and medical personnel.
Earlier, some 60,000 doses of Pfizer and AstraZeneca vaccines allocated to the Palestinians
A worker unloads a refrigerated truck carrying the first delivery of coronavirus vaccine via the United Nations COVAX program supporting poorer areas, to be kept at Palestinian Authority's storage facility in the West Bank city of Nablus, on March 17, 2021. — JAAFAR ASHTIYEH/AFP via Getty Images

The Palestinian Authority received more than 60,000 coronavirus vaccine doses under the global COVAX scheme Wednesday after months of waiting to inoculate millions of Palestinians living in the occupied territories.  

“Those vaccines being sent to the West Bank and Gaza will be critical tools in our fight against the pandemic and for socioeconomic recovery,” said the UN special coordinator for the Middle East peace process, Tor Wennesland. 

The vaccinations were provided by COVAX, the World Health Organization's global vaccine initiative aimed at providing vaccinations to less developed countries. Over the next year, COVAX is scheduled to provide enough vaccines for a million Palestinians, roughly 20% of the population. 

The vaccines — 37,000 Pfizer/BioNTech doses and 24,000 AstraZeneca doses — arrived in Ramallah on Wednesday. Roughly a third of the vaccine supplies will go to Gaza and the rest to the Palestinian Authority, which manages the autonomous areas of the West Bank. 

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish